Although Hoki et al. did not evaluate hepcidin/ferritin ratio in their study, median levels of ferritin and hepcidin data from control group and patients with NASH indicate that hepcidin/ferritin ratio is lower in NASH. The gene discussed is HAMP; the disease is metabolic dysfunction-associated steatohepatitis.